Abingdon, MD, United States of America

Donald J Kyle

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 11 EPO patents. Top assignees: Scios Inc., Scios Nova, Inc., Nova Pharmaceutical Corporation. Active years: 1988-2026.

USPTO Granted Patents = 16 

% Patents Active = 100.0


 

Average Co-Inventor Count = 1.9

ph-index = 6

Forward Citations = 119(Granted Patents)


Location History:

  • Baltimore, MD (US) (1988 - 1991)
  • Mountain View, CA (US) (1998)
  • Abington, MD (US) (2002)
  • Abingdon, MD (US) (1995 - 2004)

Company Filing History:


Years Active: 1988-2026

Loading Chart...
Loading Chart...
Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovations of Donald J. Kyle

Introduction

Donald J. Kyle is an accomplished inventor based in Yardley, PA (US). He has made significant contributions to the field of innovation, although he currently holds no patents. His career has been marked by his work with notable companies, including Purdue Pharma L.P. and Euro-Celtique S.A.

Latest Patents

As of now, Donald J. Kyle has not registered any patents. This does not diminish his impact in the industry, as his experience and knowledge contribute to the advancement of various projects.

Career Highlights

Throughout his career, Donald has worked with reputable organizations, gaining valuable experience and insights. His tenure at Purdue Pharma L.P. and Euro-Celtique S.A. has allowed him to collaborate with other professionals in the field.

Collaborations

Donald has had the opportunity to work alongside talented individuals such as Michele Hummel and Garth Whiteside. These collaborations have enriched his professional journey and fostered innovation.

Conclusion

In summary, Donald J. Kyle is a dedicated inventor whose career reflects a commitment to innovation and collaboration. His work with prominent companies and talented colleagues showcases his contributions to the field, even in the absence of patents.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…